Growth Metrics

TELA Bio (TELA) Shares Outstanding (Weighted Average) (2018 - 2025)

TELA Bio has reported Shares Outstanding (Weighted Average) over the past 8 years, most recently at $14.7 million for Q4 2025.

  • Quarterly results put Shares Outstanding (Weighted Average) at $14.7 million for Q4 2025, up 149.83% from a year ago — trailing twelve months through Dec 2025 was $14.7 million (up 149.83% YoY), and the annual figure for FY2025 was $14.7 million, up 149.83%.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $14.7 million at TELA Bio, down from $45.4 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for TELA hit a ceiling of $45.4 million in Q3 2025 and a floor of $88556.0 in Q3 2021.
  • Median Shares Outstanding (Weighted Average) over the past 5 years was $14.5 million (2021), compared with a mean of $14.0 million.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): crashed 99.58% in 2024 and later surged 51191.61% in 2025.
  • TELA Bio's Shares Outstanding (Weighted Average) stood at $14.5 million in 2021, then plummeted by 99.39% to $88556.0 in 2022, then surged by 25723.96% to $22.9 million in 2023, then crashed by 74.25% to $5.9 million in 2024, then surged by 149.83% to $14.7 million in 2025.
  • The last three reported values for Shares Outstanding (Weighted Average) were $14.7 million (Q4 2025), $45.4 million (Q3 2025), and $45.3 million (Q2 2025) per Business Quant data.